The effect of an HMG-CoA reductase inhibitor on arteriosclerotic nanoplaque formation and size in a biosensor model. [electronic resource]
Producer: 20040413Description: 635-47 p. digitalISSN:- 0956-5663
- Adsorption
- Arteriosclerosis -- blood
- Biosensing Techniques -- methods
- Calcinosis -- blood
- Calcium -- metabolism
- Coated Materials, Biocompatible -- chemical synthesis
- Diabetes Mellitus, Type 2 -- complications
- Fatty Acids, Monounsaturated -- therapeutic use
- Fluvastatin
- Heparan Sulfate Proteoglycans -- chemistry
- Humans
- Hydroxymethylglutaryl-CoA Reductase Inhibitors -- therapeutic use
- Hypolipidemic Agents -- therapeutic use
- Indoles -- therapeutic use
- Lipoproteins -- blood
- Materials Testing
- Models, Biological
- Particle Size
- Silicon Dioxide -- metabolism
- Surface Properties -- drug effects
- Treatment Outcome
No physical items for this record
Publication Type: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.